Core Viewpoint - Predictive Oncology has initiated a digital asset treasury strategy focused on the Aethir ecosystem and its native utility token, ATH, aiming to enhance access to affordable AI infrastructure and drive innovation in drug discovery [3][5][11]. Q3 2025 and Recent Highlights - The company reported a significant development in September 2025, launching a digital asset treasury strategy centered on ATH, which is expected to democratize AI access and address the demand for advanced computing power [3][5]. - Predictive Oncology's partnership with Aethir aims to leverage the latter's decentralized GPU network to provide enterprise-grade AI solutions at lower costs [3][5]. - The company appointed Shawn Matthews to its Board of Directors, enhancing its leadership team [5]. Q3 2025 Financial Summary - The company raised approximately $50.8 million in cash and received in-kind contributions of ATH valued at about $292.7 million through private placements [5]. - As of November 10, 2025, Predictive Oncology held approximately 5.70 billion ATH, with a market value of around $152.8 million, based on a price of $0.0268 per ATH [5]. - The company aims to utilize ATH to create a Strategic Compute Reserve, facilitating enterprise demand for computing power [5][11]. Q3 2025 Financial Results - For the quarter ended September 30, 2025, the company reported revenue of $3,618, a slight decrease from $3,907 in the same period of 2024 [10][17]. - General and administrative expenses increased to $2.6 million, primarily due to higher legal fees and stock-based compensation [10][17]. - The company recorded a net loss of $77.65 million for the quarter, significantly higher than the loss of $3.09 million in Q3 2024, largely due to a derivative liability of $74.4 million related to the digital asset strategy [10][17]. Balance Sheet Overview - As of September 30, 2025, the company had total assets of approximately $3.14 billion, down from $4.97 billion as of December 31, 2024 [14][15]. - Current liabilities increased significantly to approximately $79.49 million, compared to $3.59 million at the end of 2024 [15]. - The stockholders' deficit improved to $77.43 million from $202.61 million as of December 31, 2024 [15].